Alyeska Investment Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-401,865
| Closed | -$33.1M | – | 542 |
|
|
2024
Q2 | $33.1M | Buy |
401,865
+151,865
| +61% | +$12.5M | 0.19% | 147 |
|
|
2024
Q1 | $21.8M | Sell |
250,000
-134,944
| -35% | -$11.8M | 0.13% | 201 |
|
|
2023
Q4 | $37.1M | Buy |
384,944
+249,944
| +185% | +$24.1M | 0.25% | 128 |
|
|
2023
Q3 | $11.9M | Sell |
135,000
-55,000
| -29% | -$4.87M | 0.08% | 260 |
|
|
2023
Q2 | $16.5M | Sell |
190,000
-148,857
| -44% | -$12.9M | 0.12% | 212 |
|
|
2023
Q1 | $33M | Sell |
338,857
-161,615
| -32% | -$15.7M | 0.29% | 108 |
|
|
2022
Q4 | $51.8M | Sell |
500,472
-74,595
| -13% | -$7.72M | 0.54% | 63 |
|
|
2022
Q3 | $48.7M | Buy |
575,067
+435,539
| +312% | +$36.9M | 0.57% | 56 |
|
|
2022
Q2 | $11.6M | Buy |
+139,528
| New | +$11.6M | 0.13% | 194 |
|
|
2021
Q1 | – | Sell |
-51,888
| Closed | -$4.55M | – | 724 |
|
|
2020
Q4 | $4.55M | Sell |
51,888
-175,515
| -77% | -$15.4M | 0.06% | 286 |
|
|
2020
Q3 | $17.3M | Buy |
227,403
+105,945
| +87% | +$8.06M | 0.26% | 119 |
|
|
2020
Q2 | $15M | Sell |
121,458
-157,164
| -56% | -$19.4M | 0.23% | 145 |
|
|
2020
Q1 | $23.5M | Sell |
278,622
-48,490
| -15% | -$4.1M | 0.47% | 73 |
|
|
2019
Q4 | $27.7M | Buy |
327,112
+122,633
| +60% | +$10.4M | 0.36% | 100 |
|
|
2019
Q3 | $13.8M | Sell |
204,479
-19,101
| -9% | -$1.29M | 0.2% | 145 |
|
|
2019
Q2 | $19.2M | Buy |
+223,580
| New | +$19.2M | 0.25% | 124 |
|
|
2018
Q4 | – | Sell |
-2,970
| Closed | -$288K | – | 324 |
|
|
2018
Q3 | $288K | Sell |
2,970
-554,731
| -99% | -$53.8M | ﹤0.01% | 354 |
|
|
2018
Q2 | $52.5M | Buy |
557,701
+3,305
| +0.6% | +$311K | 0.47% | 79 |
|
|
2018
Q1 | $44.9M | Sell |
554,396
-217,319
| -28% | -$17.6M | 0.37% | 93 |
|
|
2017
Q4 | $68.8M | Buy |
771,715
+56,534
| +8% | +$5.04M | 0.55% | 67 |
|
|
2017
Q3 | $66.6M | Sell |
715,181
-21,540
| -3% | -$2M | 0.5% | 65 |
|
|
2017
Q2 | $66.9M | Buy |
736,721
+38,564
| +6% | +$3.5M | 0.56% | 62 |
|
|
2017
Q1 | $61.3M | Sell |
698,157
-174,544
| -20% | -$15.3M | 0.5% | 60 |
|
|
2016
Q4 | $72.3M | Buy |
872,701
+64,453
| +8% | +$5.34M | 0.6% | 41 |
|
|
2016
Q3 | $74.8M | Sell |
808,248
-311,964
| -28% | -$28.9M | 0.69% | 30 |
|
|
2016
Q2 | $87.2M | Buy |
1,120,212
+923,491
| +469% | +$71.8M | 0.82% | 19 |
|
|
2016
Q1 | $16.2M | Buy |
196,721
+181,727
| +1,212% | +$15M | 0.15% | 201 |
|
|
2015
Q4 | $1.57M | Buy |
+14,994
| New | +$1.57M | 0.02% | 311 |
|
|
2015
Q3 | – | Sell |
-139,221
| Closed | -$19M | – | 459 |
|
|
2015
Q2 | $19M | Buy |
139,221
+26,670
| +24% | +$3.65M | 0.22% | 151 |
|
|
2015
Q1 | $14M | Sell |
112,551
-66,672
| -37% | -$8.31M | 0.19% | 175 |
|
|
2014
Q4 | $16.2M | Buy |
179,223
+4,648
| +3% | +$420K | 0.28% | 126 |
|
|
2014
Q3 | $12.6M | Buy |
+174,575
| New | +$12.6M | 0.26% | 144 |
|